Single Fixed Low-Dose Rituximab As Induction Therapy Suppresses De Novo Donor-Specific Anti-Hla Antibody Production in ABO Compatible Living Kidney Transplant Recipients.
PLoS ONE(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PLoS ONE(2019)